EchelonHealthcare Partners

Echelon

Healthcare Partners

MSO Growth Advisory & Buy-Side Deal Origination

Institutional Growth Capital & Strategic Recapitalizations for Independent Healthcare Practices.

We partner with leading clinical practice owners and lower-middle-market private equity funds to unlock equity, streamline back-office operations, and scale MSO platforms—delivering sustainable financial outcomes grounded in ethical practice.

The Dual Value Proposition

Structured outcomes for practice owners and institutional capital.

For Independent Practice Owners

Unlock Capital Without Compromising Clinical Autonomy

  • Equity Realization

    Monetize 60%–80% of your practice value today while retaining equity upside in the growing MSO platform.

  • Administrative Relief

    Eliminate back-office friction—billing, HR, compliance, and payer contracting—so you can focus on patient care.

  • Preserve Legacy

    Maintain your practice culture and local identity with zero clinical interference.

For Private Equity Partners

Proprietary Off-Market Deal Flow

  • High-Conviction Origination

    Access unbrokered, off-market clinical practices doing $1M to $5M+ in EBITDA.

  • Pre-Vetted Platforms

    Deal candidates pre-screened for payer mix, provider retention, clean billing standards, and growth potential.

  • MSO Turnkey Structuring

    Seamless navigation of CPOM (Corporate Practice of Medicine) regulations and Friendly PC alignment.

Core Services

Precision advisory across originations and MSO platform growth.

Buy-Side Deal Origination

Targeted, proprietary sourcing for lower-middle-market PE funds, healthcare holding companies, and platform MSOs seeking strategic add-ons ($1M–$5M EBITDA target range).

MSO Growth Advisory

Strategic consulting for independent multi-location clinics looking to build, optimize, or recapitalize their Management Services Organization (MSO) back-office framework.

Strategic Recapitalizations

Guiding practice founders through majority and minority equity partnerships, succession planning, and growth capital deployment.

Investment Criteria

Clear parameters for high-conviction platform opportunities.

EBITDA Range

$1M – $5M

Target earnings profile for add-on and platform candidates

Revenue Range

$5M – $25M

Aligned with lower-middle-market clinical enterprises

Ethical Foundation & Operational Approach

Building Enterprise Value Through Clinical Excellence

We believe the highest financial valuations are a natural byproduct of exceptional patient care and ethical operations. Our advisory process prioritizes long-term platform stability, provider retention, and clinical integrity above short-term transactional velocity.

Confidential Inquiry

Initiate a Confidential Discussion

Whether you are a practice founder evaluating growth options or a PE partner seeking proprietary deal flow, let's schedule a discrete conversation.

Private, bilateral introductions only

Off-market dialogue with accredited institutional partners

Responses typically within one business day